Selected article for: "genome organization and viral genome"
Author: Sakr, Masarra M.; Elsayed, Noha S.; El-Housseiny, Ghadir S.
Title: Latest updates on SARS-CoV-2 genomic characterization, drug, and vaccine development; a comprehensive bioinformatics review
  • Cord-id: 36iz465o
  • Document date: 2021_2_27
    • ID: 36iz465o
    Snippet: Amid the COVID-19 outbreak, several bioinformatic analyses have been conducted on SARS-CoV-2 virus genome. Numerous studies rushed to fill the gap about this novel virus. Comparison with other related sequences, structural predictions of the produced proteins, determination of variations in amino acid residues and depiction of possible drug and vaccine targets have been the focus of scientific research from the beginning of this year. In addition to discussing the viral taxonomy, clinical featur
    Document: Amid the COVID-19 outbreak, several bioinformatic analyses have been conducted on SARS-CoV-2 virus genome. Numerous studies rushed to fill the gap about this novel virus. Comparison with other related sequences, structural predictions of the produced proteins, determination of variations in amino acid residues and depiction of possible drug and vaccine targets have been the focus of scientific research from the beginning of this year. In addition to discussing the viral taxonomy, clinical features, life cycle, and genome organization, this review will focus on the recent updates in genome and viral proteins characterization and potential therapeutic and vaccine candidates developed so far. Comparative studies with related genomes and proteins provide understanding for the viral molecular mechanisms and suggest targets for therapeutics and vaccinology trials to stop the escalation of this new virus. This pandemic, with its resulting social and economic afflictions, will definitely have significant marks on our lives in the following years.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and active site: 1, 2
    • accessory protein and acute ards respiratory distress syndrome: 1
    • accurate design and active site: 1
    • acid sialic and active site: 1, 2, 3, 4, 5, 6
    • acid sialic and acute ards respiratory distress syndrome: 1, 2
    • active site and acute ards respiratory distress syndrome: 1, 2
    • acute ards respiratory distress syndrome and ade antibody dependent enhancement: 1, 2